Tid Tittel Kategori Vedlegg
29.09.2026
09:19
SoftOx Solutions AS: SoftOx attracts renowned inhaled antimicrobial expert Dr. Bruce Montgomery to lead Clinical Advisory Board ahead of Phase 2b -
1
23.09.2026
13:09
SoftOx Solutions AS: Analyst Group Initiates Coverage of SoftOx Solutions and Comments on the H1 2026 Report - -
23.09.2026
08:00
SoftOx Solutions AS: Half Year Report 2026 -
1
27.08.2026
08:18
SoftOx Solutions AS: New Share Capital - -
11.08.2026
10:35
SoftOx Solutions AS: FIRST PATIENT DOSED IN SIS-03 PROOF-OF-CONCEPT PATIENT TRIAL -
1
07.07.2026
15:24
SoftOx Solution AS: Mandatory notification of trade by primary insider related to the Private Placement and Debt Conversion. INSIDEHANDEL INS
1
06.07.2026
20:05
SoftOx Solutions AS: Private Placement Resolved - -
26.06.2026
09:00
SoftOx Solutions AS: POSITIVE TOPLINE SAFETY DATA FROM SIS-03 DOSE-ESCALATION PHASE -
1
24.06.2026
11:47
SoftOx Solutions AS: Minutes from the General Meeting -
1
24.06.2026
08:00
SoftOx Solutions AS: First Quarter Report 2026 -
1
18.06.2026
13:54
SoftOx Solutions AS: New Share Capital - -
09.06.2026
09:48
SoftOx Solutions AS: Notice of General Assembly -
1
09.06.2026
08:00
SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited - -
08.06.2026
09:00
SoftOx Solutions AS: SIS-03 DOSE-ESCALATION PHASE COMPLETED AND INITIATION OF PROOF-OF-CONCEPT PHASE -
1
05.06.2026
09:44
SoftOx Solutions AS: FIRST PARTICIPANT ENROLLED IN BIODEFENCE-FOCUSED SIS-02 PHASE 1 CLINICAL STUDY -
1
27.05.2026
08:00
SoftOx Solutions AS: Annual Report 2025 RAPPORT RAP
1
21.04.2026
13:44
SoftOx Solutions AS: New Share Capital - -
13.04.2026
08:31
SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited - -
25.03.2026
08:00
SoftOx Solutions AS: Fourth Quarter Report 2025 -
1
24.03.2026
21:36
SoftOx Solutions AS: New Share Capital - -
11.03.2026
10:00
SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited - -
03.03.2026
08:24
SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03) - -
25.02.2026
08:00
SoftOx Defense Solutions AS: HPRA Approves SIS-02 Phase 1 Trial, Strengthening Dual-Use and Preparedness Strategy - -
04.02.2026
12:43
SoftOx Solutions AS: New Share Capital - -
23.01.2026
14:36
SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited - -